A detailed history of Stableford Capital Ii LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Stableford Capital Ii LLC holds 15,349 shares of ABT stock, worth $1.75 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
15,349
Previous 15,353 0.03%
Holding current value
$1.75 Million
Previous $1.6 Million 9.66%
% of portfolio
0.69%
Previous 0.62%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$100.07 - $118.13 $400 - $472
-4 Reduced 0.03%
15,349 $1.75 Million
Q2 2024

Jul 23, 2024

BUY
$100.73 - $112.44 $942,127 - $1.05 Million
9,353 Added 155.88%
15,353 $1.6 Million
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $604,680 - $673,740
6,000 New
6,000 $654,000
Q2 2022

Aug 08, 2022

SELL
$102.07 - $123.37 $2.05 Million - $2.48 Million
-20,086 Reduced 77.0%
6,000 $656,000
Q1 2022

Apr 11, 2022

SELL
$114.02 - $139.04 $2,394 - $2,919
-21 Reduced 0.08%
26,086 $3.22 Million
Q4 2021

Jan 28, 2022

BUY
$115.53 - $141.46 $673,193 - $824,287
5,827 Added 28.73%
26,107 $3.23 Million
Q3 2021

Oct 18, 2021

SELL
$116.66 - $129.06 $38,381 - $42,460
-329 Reduced 1.6%
20,280 $2.38 Million
Q2 2021

Aug 06, 2021

BUY
$105.79 - $124.53 $1.58 Million - $1.86 Million
14,947 Added 263.99%
20,609 $2.39 Million
Q1 2021

May 03, 2021

SELL
$108.84 - $128.23 $35,481 - $41,802
-326 Reduced 5.44%
5,662 $679,000
Q4 2020

Feb 02, 2021

BUY
$105.0 - $114.42 $628,740 - $685,146
5,988 New
5,988 $656,000
Q1 2020

Feb 10, 2021

SELL
$62.82 - $91.86 $243,741 - $356,416
-3,880 Closed
0 $0
Q4 2019

Feb 10, 2021

SELL
$78.51 - $87.4 $942 - $1,048
-12 Reduced 0.31%
3,880 $337,000
Q3 2019

Feb 10, 2021

BUY
$81.84 - $88.74 $3,191 - $3,460
39 Added 1.01%
3,892 $326,000
Q2 2019

Feb 10, 2021

SELL
$72.88 - $85.0 $12,608 - $14,705
-173 Reduced 4.3%
3,853 $324,000
Q1 2019

Feb 10, 2021

BUY
$66.22 - $80.06 $266,601 - $322,321
4,026 New
4,026 $322,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Stableford Capital Ii LLC Portfolio

Follow Stableford Capital Ii LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stableford Capital Ii LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stableford Capital Ii LLC with notifications on news.